Effective intraductal delivery of the enzyme collagenase into the pancreas is crucial to the subsequent ability to isolate viable islets. Most clinical islet transplant centers load the enzyme into the pancreas by retrograde injection using a syringe following cannulation of the pancreatic duct. An alternative approach is to perfuse the pancreas via the pancreatic duct with collagenase solution using a recirculating perfusion device system. This provides control over perfusion pressures and collagenase temperature. This study reports on our evalu ation of the delivery of Liberase™-HI into the pancreas of 14 consecutive adult multiorgan cadaveric donors. Alternate glands were procured and processed using an identical protocol with the exception of collagenase delivery. The first group of pancreases was loaded using the perfusion technique where cold (4°C) Libera-se™-HI was perfused at 80 mmHg for 5 min after which the pressure was increased to 180 mmHg. The collagenase solution was then slowly warmed to 35°C, transferred to the dissociation chamber and mechani cally dissociated, and then purified using discontinuous gradients of Ficoll. Pancreases in the second group were loaded with collagenase (28-32°C) using the syringe technique before mechanical dissociation and purification. There were no significant differences in pancreas cold ischemia, donor age, body mass index, maximum blood glucose, or serum amylase of the donors between the two groups. Mean collagenase diges tion time in the digestion chamber was not different between the two groups; however, the amount of undigested tissue remaining after dissociation was significantly higher in the syringe-loaded group (15.3 ± 2.6 g vs. 4.6 ± 2.1 g, mean ± SEM, p < 0.05). Postdigestion recovery of islets was 471 ± 83 x 10 3 IE in the perfusion group compared with 391 ± 57 x 10 3 IE for the syringe-loaded group. Postpurification recovery was higher in the perfused group (379 + 45 vs. 251 ±28 x 10 3 IE, /?<0.05, two-tailed paired /-test). No difference in in vitro islet viability was observed between the two groups following glucose perifusion with the calculated stimulation index of 4.6 ± 0.6 for the perfusion group and 4.2 ± 0.7 for the syringe-loaded group. Controlled perfusion via the pancreatic duct allows the effective delivery of the enzyme achieving maximal distension to all regions of the pancreas leading to an increased recovery of the islets with no detrimental effect on subsequent in vitro islet function.
INTRODUCTION
Islet transplantation may become a viable option for patients with insulin-dependent diabetes mellitus (IDDM). To achieve this goal, transplantation of an islet mass exceeding 6000 islet equivalents (IE) per kilogram recipient body weight is generally required (2) . In se lected cases, transplantation of this critical mass has pro duced insulin independence posttransplant (2, 16, 18, 21) . Current methods used to isolate and purify human islets have not advanced to the point where sufficient islets can be consistently recovered reliably from one cadav eric donor for transplantation into an immunosuppressed patient with long-standing IDDM.
In the methods currently used to isolate viable human islets, the collagenase enzyme is introduced into the pan creas by retrograde injection (300-500 ml) via the main pancreatic duct using multiple syringes with no attention paid to loading pressures (12, 17) . An alternate approach of collagenase delivery, which was first described by Horaguchi and Merrell (3) and further refined by War nock et al. (19, 22) , is to use a recirculating pump system to deliver the collagenase via the pancreatic duct. This system permits control of perfusion pressure and tem perature of the system during loading of the enzyme into the pancreas. Observations in a previous preliminary study by Warnock et al. (22) , using a split pancreas pro tocol, found a higher recovery of islets from the proxi-mal lobe of the pancreas following controlled perfusion.
No significant improvements in islet yields were ob served in the distal segments. This study was completed a number of years ago when the methods used to isolate islets were not standardized and utilized a collagenase that was not purified and had lot-to-lot variation. Now that methods for human islets isolation have been stan dardized, the aim of this study was to prospectively compare two well-defined methods of delivering colla genase into the pancreas. Also this study was completed with Liberase™-HI, a purified collagenase enzyme blend, thus eliminating the issue of enzyme variability between the two experimental groups (1, 9) .
MATERIALS AND METHODS
Pancreases were recovered from brain-dead cadaveric donors following informed consent. Pancreases were re moved following in situ vascular perfusion using cold UW solution as part of a multiorgan procurement (4) . Requests were made to procurement teams to avoid ob struction of fluid outflow from the splenic vein during the organ harvest. Donor-related factors including age, body mass index, minimum and maximum observed blood glucose, serum amylase, and the duration of cold ischemia of the pancreas were recorded (7) . Cause of death was categorized into three groups: 1) traumatic (motor vehicle accidents, motor cycle accidents, and gun shot wounds), 2) nontraumatic (carbon monoxide poi sonings, anoxia, tumors, and drug overdoses), and 3) cerebrovascular.
Islet Isolation
Pancreases were placed in cold UW solution on ice (4°C) and immediately transported to the islet isolation laboratory for processing ( Fig. 1 ). Islets were isolated using previously described techniques of collagenase di gestion and Ficoll purification (15, 19) . All vascular, fatty, and connective tissues were removed and the gland was weighed. For pancreases in both experimental groups, two cannulas (Medicut 16-gauge catheter) were inserted into the main pancreatic duct and directed to wards the head and tail of the pancreas following dissec tion of the pancreatic duct in the mid-body of the pan creas (20) . A 14-gauge Medicut catheter was inserted into the head of the pancreas and secured in place with 3-0 silk ties.
Collagenase Preparation
Vials of Liberase™-HI enzyme (Boehringer Mann heim, Indianapolis, IN) were removed from storage at -80°C, warmed to room temperature, and resuspended in 15 ml of cold Hank's balanced salt solution (HBSS) (Gibco, Grand Island, NY) (1). The same lot of Libera-se™-HI was used for this comparative study. The solu tions were placed on ice and the enzyme allowed to rehydrate for 30 min before being brought up to a volume of 500 ml in HBSS and sterile filtered using a 0.22-um cellulose acetate filter (Corning).
Intraductal Enzyme Delivery: Controlled Perfusion
Protocol Alternate glands were placed in a customized perfu sion apparatus (22) and perfused with Liberase™-HI pu rified enzyme blend. Pancreases were perfused under controlled conditions using the standard perfusion proto col with collagenase solution while maintaining constant pressure of 60-80 mmHg for the first 5 min and 160-180 mmHg for the next 5 min (22) . After 10 min of cold perfusion, the temperature of the recirculating collagen ase was slowly warmed to 35°C and then transferred to the continuous digestion device (CDD) for mechanical and enzymatic dissociation (22) .
Intraductal Enzyme Delivery: Syringe Load Protocol
The second group of pancreases was loaded with Lib-erase™-HI enzyme using the standard syringe-loading protocol. Using 60-ml syringes, prewarmed collagenase solution (28-32°C) was injected equally through the three cannulas using maximal hand pressure (> 300 mmHg) (15, 17) . The distended pancreas and all colla genase solution that had leaked out of the pancreas dur ing loading were transferred to the CDD for the mechan ical and enzymatic dissociation (22) .
Pancreas Dissociation
Both groups of pancreases were dissociated using an identical digestion protocol (17, 22) . The recirculating collagenase solution in the CDD chamber was warmed to 37°C and held at 37 ± 0.5°C throughout dissociation of the pancreas. Samples of pancreatic tissue were eval uated during the digestion, and when the majority of islets were free from exocrine tissue the digestion phase was stopped and warm (37°C) HBSS supplemented with 10% newborn calf serum (Hyclone, Logan, UT) and an tibiotics was flushed through the chamber (17, 22) . The effluent solution was cooled through a glass water col umn, collected in 500-ml conical tubes at 4°C, then centrifuged at 1500 rpm. All tissue was recombined and a prepurification sample was removed, stained with dithi zone, and assessed as previously described (8, 14) .
Purification and Islet Quantification
Pancreatic digest containing endocrine and exocrine tissue was purified using continuous gradients of Ficoll using the Cobe 2991 (COBE BCT, Inc., Lakewood, CO) (6, 10) . Samples of several layers (layers 10 through 15) of the continuous gradient were removed, stained with dithizone, and assessed as to islet purity. Islet-enriched
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Purification Figure 1 . Experimental protocol. Human pancreases were procured following in situ vascular perfusion with UW solution and loaded with Liberase™-HI using either controlled perfusion or syringe-loading techniques. Pancreases were then dissociated and purified using an identical isolation protocol.
layers were selected and collected. Islet recovery follow ing purification was assessed in duplicate by counts of dithizone-stained aliquots of the final suspension of tis sue. The islet mass was quantified and the purity of the preparations was assessed by two independent investiga tors in accordance to the criteria established at the 1989 International Workshop on Islet Assessment (14) . The number of islets in each diameter class was determined using an optical graticule. The number of islets within each size class was then converted to the standard num ber of IE, which represents the number of islets of 150 um diameter equal in volume to the sample (14) . Purity of the preparations was assessed by comparing the rela tive quantity of dithizone-stained endocrine tissue with unstained exocrine tissue.
Viability Assessment
After a minimum culture period of 24 h at 37°C in CMRL tissue culture media (Gibco) supplemented with 10% fetal calf serum (Gibco), and antibiotics in a hu midified atmosphere of 95% air and 5% C0 2 , islet func tion was assessed by glucose-stimulated perifusion (5, 13) . Duplicate samples of known numbers of islets were placed in modified Millipore chambers and perifused with Krebs (Gibco) solution containing glucose in the following concentrations: initially 2.8 mM for 60 min, then 20 mM for 60 min, and finally 2.8 mM for the remaining 60 min of the perifusion. The effluent was collected at 51, 59, 65, 69, 89, 109, 149, and 179 min, and the insulin concentration of perifusate samples was determined using the double antibody radioimmunoas say (11) . The stimulation index was determined from insulin values during glucose perifusion and represents insulin secretion by the islets during the high glucose (20 mM) stimulation period (samples taken at 65, 89, and 109 time points) over the insulin secreted during both periods of low (2.8 mM) basal insulin secretion prestimulation (51 and 59 time points) and poststimulation (149 and 179 time points).
Statistical Analysis
Islet counts following digestion and islet recovery following purification were compared between the pan creases that had been loaded with Liberase using the syringe methods or controlled perfusion via the duct. All results are expressed as mean ± SEM. Statistical analysis was performed using the SPSS statistical software pack age using Student's two-tailed f-tests between the indi vidual groups. Differences between the experimental groups were considered significant when p < 0.05.
RESULTS
Fourteen pancreases were procured from adult (20-65 years old) multiorgan cadaveric donors follow ing vascular flushing with cold UW organ preservation solution. All pancreases were processed using an identi cal isolation protocol with the exception of the methods used to load the enzyme into the pancreas. Alternate glands were loaded using either a syringe load or con trolled perfusion protocol using the same lot of Liber-ase™-HI enzyme.
A total of six pancreases, three from each experimen- Values are mean ± SEM. BMI = body mass index.
tai group, were received from collaborative transplant centers and shipped to Edmonton for processing. All re maining pancreases were procured locally and processed within 3 h of procurement. The mean ± SEM cold ische mic time from pancreas procurement to initiation of the isolation procedure was 5.7 ± 0.9 h in the syringe-loaded group compared with 4.9 ± 1.2 h in the controlled perfu sion group (p = NS, two-tailed Student's paired Mest). Three donors in the syringe-loaded group were female and the remaining four were male compared with four male and three female donors in the controlled perfusion group. Table 1 describes the donor variables that were evaluated in this study. No significant differences in the body mass index (24 ± 1.4 and 22.9 ± 1.1) or serum am ylase levels (102 ± 31 IU/1 and 79 ± 10 IU/1) in the sy ringe-loaded or controlled perfusion groups (p = NS).
The mean maximal serum blood glucose in the sy ringe-loaded group was 12.5 ±2.3 mM compared with 11.4 + 2 mM in the controlled perfusion group ip = NS, Table 1 ). One donor from each experimental group was treated with exogenous insulin therapy during the hospi talization period.
A total of five of the donors in the syringe-loaded group died as a result of cerebrovasular accidents and two had died following traumatic death, compared with four cerebrovascular, two traumatic, and one nontrau matic deaths in the controlled perfusion group.
The mean time to load the enzyme into the pancreas was 6.0 ± 0.6 min in the syringe-loaded group compared with a mean loading time of 19.2 ±1.8 min in the con trolled perfusion group (p < 0.05, Table 2 ).
We observed no differences in the enzymatic dissoci ation times in the CDD chamber for pancreases in both experimental groups with a mean digestion time of 28 ± 2.1 min in the syringe-loaded group and 29.6 ± 1.9 min in the controlled perfusion group ( Table 2 ). The amount of undigested tissue remaining in the dissociation cham ber following enzymatic dissociation and flushing of the chamber was significantly higher in the syringe-loaded group compared with the pancreases processed using the controlled perfusion protocol (15.3 ± 2.6 vs. 4.6 ± 2.1 g, p < 0.05, Table 2 ).
Following recombination of the unpurified pancreatic tissue digest, a total of 391 ± 57 x 10 3 IE was recovered from the syringe-loaded group, which was equivalent to 471 ± 83 X 10 3 IE recovered from the controlled perfu sion ( Table 3 ). This was equivalent to 4829 ± 1124 and 5474 ± 926 IE/g of pancreas, respectively. A mean total of 33.6 ± 9.4% of the islets in the syringe-loaded group was still embedded in exocrine tissue, which was lower than the 16.7 ± 10.1% observed in the controlled perfu sion experimental group (Table 3 ).
The mean postpurification recovery of islets was higher in the group of pancreases that was processed following controlled perfusion than those processed us ing syringe loading (379 ± 45 vs. 251 ± 28 IE x 10 3 , p < 0.05, Table 3 ). Yields of islets/g of processed pancreas were 3031 ± 579 IE/g in the syringe-loaded group com pared with 4367 ± 396 IE/g in the controlled perfusion group (Fig. 2) . This constituted a mean recovery follow ing purification of 66 ± 3.9% in the syringe-loaded group and 75 ±9.1% in the controlled perfusion group (Table 3 ).
In vitro viability assessment of purified islets follow ing 24-h in vitro tissue culture at 37°C was equivalent between the two experimental groups (Fig. 3 ). Insulin secretion from islets isolated using the syringe protocol had mean basal insulin secretion levels of 0.08 ±0.1 pJJ insulin/IE/min during low glucose incubation compared with 0.12 + 0.2 U.U insulin/IE/min in the islets isolated using the controlled perfusion protocol (Fig. 3 ). During for the islets isolated using the controlled perfusion pro tocol ( Fig. 3 , p = ns).
DISCUSSION
Before clinical islet transplantation can be considered an effective therapy and a viable option in the treatment of patients with insulin-dependent diabetes mellitus, sev eral key factors must be resolved.
One key issue relates to the quantity and quality of islets being transplanted. The most recent review of cases reported to the International Islet Transplant Reg istry identified the mass of islets transplanted as key fac tor in the likelihood of the patient experiencing periods of posttransplant insulin independence (2) . In their re view, the International Islet Transplant Registry found that all clinical islet transplant patients experiencing pe riods of insulin independence were transplanted with a minimum of 6000 IE/kg body weight (2) . If islet trans plantation is to become an effective treatment, there must be significant improvements in the ability to re cover large numbers of viable islets from a single donor pancreas.
Development of the purified enzyme blend, Liber-ase™-HI, is one factor that has recently been introduced to improve the recovery of islets (9) . Recoveries of iso lated islets from the human cadaveric donor have signif icantly improved following the introduction of Liber-ase™-HI as reported by the University of Miami (9) . Additionally, by providing a stable, consistent enzyme blend with less lot-to-lot variability there is an opportu nity to investigate factors in the isolation process that affect the recovery of islets from the human pancreas.
Current methods of human islet isolation incorporate the introduction of enzyme via the pancreatic duct, fol lowed by enzymatic and mechanical dissociation (9, 17) . Digested pancreatic tissue is separated from the exocrine tissue using a purification step before quantification and viability assessment.
The methods used to isolate rodent islets have been ineffective for the larger and more compact mammalian pancreases and it was not until the collagenase was de livered via the pancreatic duct were yields of islets im proved (20) . Intralobular delivery of the enzyme to the islet-exocrine interface provides a means to directly de liver the enzyme. The methods used for intraductal de livery of enzyme have been by syringe loading follow ing cannulation of the main pancreatic duct or by controlled perfusion, first described by Horaguchi and Merrell (3) , who were able to recover approximately 57% of the islet mass from the canine pancreas. This approach was further improved by our group where a stainless steel recirculating perfusion device that was ca pable of collagenase delivery under controlled pressure and temperature was utilized (19) . However, because of the increased costs associated with the manufacturing of a perfusion device, most laboratories isolating islets use the syringe injection technique.
A previous comparison by our laboratory of con trolled perfusion with syringe loading was performed us ing cadaveric donor pancreases with extended cold is chemia before islet isolation (19) . In this study the pancreas was divided into proximal and distal segments. One segment of the pancreas was perfused using crude unpurified collagenase (Sigma Type V) and the other segment of the pancreas was loaded with the same en zyme solution using the syringe technique. Distal and proximal segments of the pancreas were alternated to remove the bias of the segment of the pancreas and the load technique. Results from this study showed that sig nificantly more islets per gram of processed pancreas were recovered if the proximal segments of pancreas were loaded with the enzyme using controlled perfusion protocol (19) . Perfused distal segment yields were statis tically equivalent with the syringe-loaded group despite the increased ease of enzymatic dissociation observed in the perfused group (19) .
Although the experimental protocol of inserting and loading the enzyme into the pancreas using multiple cut downs was consistent between the two experimental groups, we observed a significantly higher amount of undigested pancreatic tissue in the group of pancreases that was loaded using the syringe protocol. In the con trolled perfusion protocol the enzyme is recirculated through the pancreases for approximately 15 min com pared with the syringe-loaded group, which is loaded with collagenase once before being placed in the cham ber for mechanical and enzymatic dissociation.
During the initial cold perfusion phase of the con trolled perfusion protocol the pancreas typically remains firm and undistended. However, when the temperature of the recirculating collagenase solution is slowly warmed we observed a drop in the manometer monitor ing the perfusion pressure as the temperature in the pan creas increases. By increasing flow of the perfusion de vice we were able to maintain the perfusion pressure within our experimental protocol guidelines. Our specu-lation is that there is a collapse of the fine distal pancre atic ductal system during extended cold storage of the pancreas. The controlled perfusion protocol, more spe cifically the initial cold perfusion, permits the gradual opening of the fine pancreatic ductal system slowly over time, resulting in improved collagenase delivery to all regions of the pancreas.
Enzyme loading using the syringe method is typically accomplished at temperatures of 30-32°C. There is only one opportunity to achieve maximal distention of the pancreas and for the enzyme to reach the islet-exocrine interface before enzymatic digestion is initiated. This may account for the increased amounts of undigested pancreatic tissue that remain in the chamber following enzymatic dissociation.
CONCLUSION
Any improvements in the methods to increase the re covery of islets while maintaining functional viability of the islets would significantly improve the field of clini cal islet transplantation. This series of experiments ex amined a key step in the isolation of human islets, the delivery of the enzyme to the islet-exocrine interface. Controlled perfusion via the duct permits a more con trolled delivery of the enzyme to all regions of the pan creas, leading to an improved recovery of islets without compromising the functional viability.
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